cspc pharmaceuticals - Search News

News

AstraZeneca, CSPC

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

The Wall Street Journal on MSN · 3d

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.

Stocktwits on MSN · 3d

AstraZeneca Inks $5.3B Deal With CSPC Pharma For Developing New Oral Drug Candidate, But Retail’s In No Mood To Cheer

AstraZeneca (AZN) on Friday announced a strategic research collaboration with China-based CSPC Pharmaceuticals Group to advance the development of oral drug candidates with the potential to treat multiple chronic diseases.

AstraZeneca, CSPC Launch AI-Powered Collaboration for Oral Drug Discovery

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

13hon MSN

Health Care Roundup: Market Talk

Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.

Business Weekly7h

AstraZeneca takes spending on novel China projects to around $8bn

Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...

Pharmaceutical Technology on MSN3d

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results